DekaBank Deutsche Girozentrale Sells 41,233 Shares of UiPath Inc. (NYSE:PATH)

DekaBank Deutsche Girozentrale cut its holdings in UiPath Inc. (NYSE:PATH) by 47.1% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 46,226 shares of the healthcare company’s stock after selling 41,233 shares during the period. DekaBank Deutsche Girozentrale’s holdings in UiPath were worth $585,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently made changes to their positions in the company. ORG Partners LLC raised its position in shares of UiPath by 875.6% in the 1st quarter. ORG Partners LLC now owns 1,239 shares of the healthcare company’s stock worth $27,000 after acquiring an additional 1,112 shares in the last quarter. Future Financial Wealth Managment LLC bought a new stake in UiPath in the 3rd quarter valued at about $26,000. JTC Employer Solutions Trustee Ltd bought a new stake in UiPath in the 3rd quarter valued at about $26,000. Hantz Financial Services Inc. bought a new stake in UiPath in the 2nd quarter valued at about $28,000. Finally, Advisors Asset Management Inc. increased its position in UiPath by 35.0% in the 1st quarter. Advisors Asset Management Inc. now owns 3,037 shares of the healthcare company’s stock valued at $69,000 after buying an additional 787 shares in the last quarter. 62.50% of the stock is owned by institutional investors.

Insider Activity at UiPath

In related news, CFO Ashim Gupta sold 47,671 shares of the company’s stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $12.07, for a total value of $575,388.97. Following the transaction, the chief financial officer now owns 849,917 shares in the company, valued at approximately $10,258,498.19. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 22.37% of the stock is owned by company insiders.

UiPath Stock Up 1.7 %

Shares of NYSE PATH opened at $12.57 on Friday. UiPath Inc. has a twelve month low of $10.37 and a twelve month high of $27.87. The stock’s 50 day moving average price is $12.54 and its 200-day moving average price is $13.82. The company has a market capitalization of $6.91 billion, a PE ratio of -62.85 and a beta of 0.87.

UiPath (NYSE:PATH) last announced its earnings results on Thursday, September 5th. The healthcare company reported $0.04 earnings per share for the quarter, topping analysts’ consensus estimates of $0.03 by $0.01. UiPath had a negative return on equity of 3.98% and a negative net margin of 8.13%. The firm had revenue of $316.00 million for the quarter, compared to the consensus estimate of $303.69 million. During the same quarter in the previous year, the business earned ($0.09) EPS. The company’s revenue was up 10.0% compared to the same quarter last year. As a group, research analysts expect that UiPath Inc. will post -0.23 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

PATH has been the subject of a number of research analyst reports. Needham & Company LLC reaffirmed a “hold” rating on shares of UiPath in a research report on Wednesday, October 23rd. Morgan Stanley reaffirmed an “equal weight” rating and issued a $15.00 target price on shares of UiPath in a research report on Friday, September 6th. Evercore ISI boosted their target price on UiPath from $13.00 to $16.00 and gave the company an “in-line” rating in a research report on Friday, September 6th. JPMorgan Chase & Co. decreased their price objective on UiPath from $19.00 to $17.00 and set an “overweight” rating for the company in a report on Wednesday, October 23rd. Finally, BMO Capital Markets boosted their price objective on UiPath from $14.00 to $15.00 and gave the stock a “market perform” rating in a report on Friday, September 6th. Sixteen equities research analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $17.47.

UiPath Company Profile

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.